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Introduction
In continuation to a series of works on the efficacy of a poten-
tized homeopathic drug, Arsenicum album, in the amelioration
of arsenic-induced toxicity in mice (1–8), we felt the necessity
of testing the efficacy of a potentized homeopathic drug,
Mercurius solubilis, derived from a salt of mercury, Mercurius
solubilis Hahnemanni (a precipitation of mercurous-ammo-
nium-nitrate complex) in ameliorating mercuric chloride-
induced genotoxicity in mice as well. In recent years mercury
poisoning has assumed an alarming proportion in the environ-
ment, and a search for effective antagonists of mercury has
already begun. Exposure to mercury salts, carried to various
water bodies as run-offs or factory effluent, has been the
source of accumulation of this poisonous metal and its salts in
fish inhabiting polluted water, endangering the people who
may consume them. Methyl mercury-induced chromosomal
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Mercury and its derivatives have become an alarming environmental problem, necessitating the search
for effective antagonists, including homeopathic drugs, which are generally used in micro doses and are
devoid of any palpable side-effects. On the basis of homeopathic similia principle, two potencies of
Mercurius solubilis (Merc Sol-30 and Merc Sol-200) were tested by three administrative modes, i.e. pre-
feeding, post-feeding and combined pre- and post-feeding, for their possible efficacy in ameliorating
mercuric chloride-induced genotoxicity in mice. Healthy mice, Mus musculus, were intraperitoneally
injected with 0.06% solution of mercuric chloride at the rate of 1 ml/100 g of body weight, and assessed
for genotoxic effects through conventional endpoints. i.e. chromosome aberrations, micronuclei, mitotic
index and sperm head abnormality, keeping suitable controls. Mercuric chloride-treated mice were
divided into three sub-groups, which were orally administered with the drug prior to, after and both prior
to and after injection of mercuric chloride, and their genotoxic effects were analysed at specific inter-
vals of fixation. Mercuric chloride treatment generally produced more chromosome aberations,
micronuclei and sperm head anomaly in mice, but the mitotic index appeared to be slightly reduced.
While chromosome aberations, micronuclei and sperm head anomaly were generally reduced in the
drug-fed series, the mitotic index showed an apparent increase. In most cases, the combined pre- and
post-feeding mode appeared to show the maximum amelioration, followed by post-feeding and pre-
feeding, in that order. The amelioration by Merc Sol-200 appeared to be slightly more pronounced. We
conclude that potentized homeopathic drugs can serve as possible anti-genotoxic agents against specific
environmental mutagens, including toxic heavy metals.
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derivative work this must be clearly indicated.damages have been reported in lymphocyte culture (9) of
23 persons who ingested fish exposed to mercury-contaminated
water. Even accidental exposure to mercury, e.g. in 1965 at
Minamata and Niigata in Japan, has been shown to cause
considerable genotoxic damage, directly or indirectly, to human
beings, noticeable even in successive generations. Similarly, the
detrimental effects of mercury on cellular systems in different
mammals have been well-documented (10). Influence of mer-
cury intoxication has also been studied in rat hepatic microso-
mal proteins (11) and the cytogenetic effects of methyl mercury
have been reviewed by Ramel (12,13). Further, mixtures of cad-
mium chloride and mercuric chloride have also been reported
to enhance cytotoxic effects in rat hepatocyte culture cells (14).
However, there has been no documented earlier attempt to test
the efficacy of any potentized homeopathic drug for the poten-
tial ability to reduce mercury-induced genotoxicity. Therefore,
the present investigation was undertaken to evaluate the relative
efficacy, if any, of two microdoses of the homeopathic
drug Mercurius solubilis (namely, Merc Sol-30 and Merc 
Sol-200) in ameliorating mercury-induced genotoxicity in
mice. Further, the relative efficacy of three modes of adminis-
tration, i.e. pre-feeding, post-feeding and combined pre- and
post-feeding, for each potency has also been evaluated.
Materials and Methods
Mice
Inbred lines of mice (Mus musculus), cultured and maintained
on an artificial standard diet and water ad libitum (under
the supervision of the animal welfare committee, University
of Kalyani), were used for the present study. Generally,
3–4-months-old healthy adult mice of both sexes weighing
22–28 g were selected for the study.
Treatment of Test Chemical
After a brief range-finding trial, 0.006% solution of mercuric
chloride (6 mg dissolved in 100 ml of distilled water)
was found to be a mild sub-lethal dose, which was enough
for producing quantifiable genotoxic effects. Therefore,
this dose was intra-peritoneally pushed into mice through a sin-
gle injection at the rate of 1 ml/100 g of body weight. Injected
mice were divided into two groups: (i) those fed the diluted
homeopathic drug in either potency, and (ii) those fed diluted
succussed alcohol (i.e. Alc-30 or Alc-200), which served as
positive controls. A third group of normal healthy mice, which
were not injected with mercuric chloride, served as the negative
controls. Another set of negative controls was maintained with
mice not injected with mercuric chloride, but fed with either
potency of the homeopathic drug, to examine if the homeo-
pathic drug fed to normal healthy mice produced any genotoxic
effects in them. Mice were sacrificed at six intervals of fixation:
6, 12, 24, 48, 72 and 96 h after mercury treatment. Five mice
were used for each of the drug-fed (T) and control (C) series at
each fixation period.
Preparation of Homeopathic Stock Solution and
Feeding Procedure
Aliquots (0.06 ml each) of the homeopathic drugs, Merc 
Sol-30 and Merc Sol-200 (procured from HAPCO, 165,
Bipin Behari Ganguli Street, Kolkata) were diluted separately
with 20 ml of distilled water (normal practice for human sub-
jects), which formed the stock solution of the drug, Merc Sol-
30 and Merc Sol-200, respectively. Samples of 0.06 ml of the
stock solution (this dilution was made due to the size differ-
ence between mice and humans) were orally fed to mice with
the aid of a special pipette (three times a day for Merc Sol-30,
i.e. at 6 am, 12 noon and 6 pm, and twice daily for Merc 
Sol-200, i.e. at 6 am and 6 pm, until sacrifice). Similarly,
0.06 ml of succussed alcohol (Alc-30 or Alc-200) was diluted
with 20 ml of distilled water to make the stock solution of
alcohol. Again, 0.06 ml of succussed alcohol was similarly fed
orally to the control sets of mice at the corresponding times of
drug-feeding.
Cytogenetic Methods
The standard cytogenetic protocols, i.e. assays of chromosome
aberrations, micronuclei, mitotic index and sperm head anom-
aly were adopted in the present study to determine the geno-
toxic effects.
Chromosome Preparation and Scoring of Chromosome
Aberations
Mice were intra-peritoneally injected with 0.025% colchicine
at a dose of 1 ml/100 g body weight 90 min before sacrifice.
Marrow of the femur was flushed in 1% sodium citrate solu-
tion at 37 C and fixed in acetic acid/ethanol (1:3). Slides were
prepared by the conventional flame drying technique followed
by Giemsa staining for scoring bone marrow chromosome
aberations. Chromosome aberations of various nature have
been pooled into two categories: the ‘major’ type comprising
aberrations like break, fragments, ring, polyploidy etc. and the
‘other’ types comprising less significant aberrations like gaps,
erosions, precocious centromeric separation, pycnosis, stretch-
ing etc. However, the combined frequency of both major and
other type aberrations only has been shown for each of the dif-
ferent series. A total of 500 bone marrow cells were observed,
taking about 100 from each of the five mice of a set for each
fixation interval.
Micronuclei Study and Determination of Mitotic Index
For micronuclei preparation, a part of the suspension of bone
marrow cells in 1% sodium citrate was smeared on clean
grease-free slides, briefly fixed in methanol and subsequently
stained with May-Grunwald followed by Giemsa.
Approximately 5000 bone marrow cells, comprising both
polychromatic erythrocytes (PCE) and normochromatic
erythrocytes (NCE) were scored, and the combined frequency
of both types only are shown in the tables.
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was scanned for micronuclei. The non-dividing and dividing
cells were recorded and their ratios calculated.
Sperm Head Anomaly Study
For sperm head anomaly, the technique of Wyrobek et al. (15)
was adopted with minor modifications. Epididymis from each
side of testis of control or treated sets of mice was dissected
out and the inner content squeezed out into 10 ml of 0.87%
normal saline separately. It was made free of fats, vas deferens
and other tissues. The content was thoroughly shaken, filtered
through a silken cloth and dropped on grease-free clean slides.
The slides were allowed to air dry and then stained by dilute
Giemsa (1 ml Giemsa in 10 ml distilled water).
Statistical Analysis and Scoring of Data
The observers were ‘blinded’ as to whether the slides they
were examining were from a treated or control series.
Students’ t-test was conducted as per standard procedure for
determining the significance level of the differences between
treated and control data.
Results
Controls
Firstly, the cytogenetic data in the group of healthy mice fed
with either potency of the homeopathic drug alone at the spec-
ified time intervals revealed that there was hardly any elevation
in the frequency of aberrations, micronuclei or sperm head
anomaly, as compared to normal mice either not receiving drug
at all or only receiving dilute succussed alcohol (being the
vehicle of the drug). In fact the mice of both positive (only
drug-fed) and negative controls (drug-unfed healthy mice)
revealed negligible cytogenetic abnormalities (within the range
of spontaneous abnormalities). Therefore, the data for one
normal control only have been incorporated in Tables 1–3 and
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Table 1. Frequency distribution of mitotic index, chromosome aberations, micronuclei, and sperm head anomaly in mice at different fixation intervals in 
pre-fed mercuric chloride-treated mice
Fixation interval Series Mitotic index Chromosome aberations Micronucleated erythrocytes Sperm head anomaly
(h) % (  SE) % increase Total (%   SE) % Suppr Total (%   SE) % Suppr Total (%   SE) % Suppr
Pre-fed with Merc Sol-30 (T1) and Alc-30 (C1)
6T 1 1.50   0.11 0.04 11.80   1.14 10.6 1.12   0.29 0.00
C1 1.46   0.17 13.20   1.38 1.12   0.28
12 T1 1.54   0.11 0.56** 16.80   2.04 (–) 0.41   0.04 22.6 2.22   0.19 (–)
C1 0.98   0.07 15.60   1.64 0.53   0.04 1.72   0.24
24 T1 1.36   0.09 0.36* 26.20   2.07 12.08 0.27   0.04 69.6*** 5.16   0.37 29.12*
C1 1.00   0.07 29.80   1.74 0.89   0.07 7.28   0.67
48 T1 0.86   0.13 0.10 31.80   1.81 14.9 0.23   0.02 75.2** 4.60   0.16 9.8
C1 0.76   0.10 37.40   2.33 0.93   0.05 5.10   0.35
72 T1 1.26   0.16 0.26 22.40   1.60 21.1* 0.49   0.05 49.4*** 2.60   0.20 19.2
C1 1.00   0.12 28.40   1.68 0.97   0.08 3.22   0.31
96 T1 1.56   0.34 0.12 17.60   1.15 27.8** 0.47   0.70 61.4*** 1.52   0.22 49.3***
C1 1.44   0.26 24.40   1.60 1.22   0.08 3.00   0.21
Pre-fed with Merc Sol-200 (T1) and Alc-200 (C1)
6T 1 1.56   0.14 0.06 12.60   0.97 8.6 1.08   0.26 3.57
C1 1.50   0.18 13.80   1.43 1.12   0.28
12 T1 1.72   0.13 0.78*** 16.00   2.15 2.4 0.33   0.05 42.1* 2.44   0.19 (–)
C1 0.94   0.05 16.40   2.01 0.57   0.09 1.84   0.19
24 T1 1.52   0.08 0.48*** 27.40   1.98 11.0 0.31   0.05 68.0** 4.90   0.29 34.6**
C1 1.04   0.11 30.80   2.04 0.97   0.06 7.50   0.62
48 T1 1.08   0.18 0.38* 31.00   2.71 17.5 0.27   0.05 73.7*** 3.74   0.29 28.3*
C1 0.70   0.10 37.60   2.65 1.03   0.02 5.22   0.40
72 T1 1.54   0.14 0.58* 21.20   1.29 25.3** 0.61   0.07 44.5** 3.10   0.23 (–)
C1 0.96   0.14 28.40   1.30 1.10   0.09 2.26   0.14
96 T1 1.98   0.18 0.62 16.20   1.38 36.2** 0.59   0.06 52.4*** 1.42   0.12 54.1***
C1 1.36   0.23 25.40   1.30 1.24   0.08 3.10   0.23
N 1.40   0.06 1.47   0.23 0.14   0.05 0.69   0.11
Suppr, Suppression; N, normal control.
*P   0.05; **P   0.01; ***P   0.001.Figures 2–7 for reasons of economy of space and clarity of
purpose. On the other hand, relevant data between the drug-fed
and succussed alcohol-fed (e.g. Alc-30- or Alc-200-fed) mice
treated with mercuric chloride were focused more to assess the
quantum of modulation that could be attributed to the feeding
of the specific potency of drug at a particular fixation interval.
In mice treated with mercuric chloride, there were distinct
elevations in the frequency of the cytogenetic parameters stud-
ied and in mice fed with either potency of Merc Sol, before
(Figs 2 and 3) or after (Figs 4 and 5), or both before and after
(Figs 6 and 7), definite modulations with respect to all the
parameters examined could be evidenced.
While in normal healthy control mice, the total frequencies
of chromosome aberrations, micronuclei and sperm head
abnormality were 1.47%, 0.14% and 0.69%, respectively,
these were considerably enhanced in the mercuric chloride-
treated mice at all intervals of fixation (Tables 1–3, Figs 2–7).
However, the percentages of mitotic index in the mercuric
chloride-treated mice were generally reduced to a varying
extent as compared to the 1.4% found in normal healthy mice.
While the mitotic index was generally increased in the drug-
fed series, to a different extent in the three modes of feed-
ing, the chromosome aberations (Fig. 1A–F), micronuclei
(Fig. 1G and H) and sperm head anomaly (Fig. 1K–O) fre-
quencies were considerably reduced in the drug-fed series, the
maximum efficacy being found in the combined pre-and post-
fed series, followed by post-fed, then pre-fed series, in that
order (Tables 1–3, Figs 2–7).
Pre-feeding
In the mercuric chloride-treated mice the mitotic indices were
found to be reduced at 12 h onwards up to 72 h, after which the
mitotic index was apparently restored to normal levels. In both
Merc Sol-30- and Merc Sol-200-fed mice the mitotic indices
were found to be elevated right from 6 h through to 96 h, the
Merc Sol-200 showing a little more mitotic index enhancing
ability than Merc Sol-30 (Table 1, Figs 2 and 3).
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Table 2. Frequency distribution of mitotic index, chromosome aberations, micronuclei, and sperm head anomaly in mice at different fixation intervals in 
post-fed mercuric chloride-treated mice
Fixation interval Series Mitotic index Chromosome aberations Micronucleated erythrocytes Sperm head anomaly
(h) % (%   SE) % increase Total (%   SE) % Suppr Total (%   SE) % Suppr Total (%   SE) % Suppr
Post-fed with Merc Sol-30 (T2) and Alc-30 (C2)
6T 2 1.24   0.16  0.08 15.80   1.55 (–) 0.70   0.11 27.1
C2 1.32   0.28 14.60   1.60 0.96   0.21
12 T2 1.76   0.09 0.68*** 12.00   2.00 31.0 0.35   0.05 28.5 1.74   0.16 17.9
C2 1.08   0.10 17.40   2.30 0.49   0.06 2.12   0.23
24 T2 1.54   0.12 0.34 26.00   1.69 13.33 0.55   0.06 32.9** 4.18   0.32 41.5***
C2 1.20   0.11 30.00   2.13 0.82   0.09 7.14   0.47
48 T2 1.22   0.13 0.74** 23.40   2.48 41.8** 0.59   0.07 42.7* 3.76   0.17 26.8
C2 0.48   0.09 40.20   3.89 1.03   0.10 5.14   0.66
72 T2 1.86   0.13 0.86** 19.20   2.48 39.6** 0.61   0.09 41.9* 2.26   0.27 23.6
C2 1.00   0.13 31.80   2.48 1.05   0.11 2.96   0.20
96 T2 2.32   0.24 0.90* 15.20   1.19 34.4** 0.57   0.04 48.1** 1.36   0.20 52.1***
C2 1.42   0.25 23.20   1.74 1.10   0.10 2.84   0.18
Post-fed with Merc Sol-200 (T2) and Alc-200 (C2)
6T 2 1.68   0.11 0.26 9.60   0.83 27.2* 0.54   0.08 51.7
C2 1.42   0.16 13.20   1.20 1.12   0.34
12 T2 1.94   0.13 0.96*** 8.40   1.03 47.5** 0.27   0.04 50.9** 2.38   0.19 (–)
C2 0.98   0.10 16.00   2.17 0.55   0.05 1.92   0.23
24 T2 1.70   0.11 0.58** 22.80   1.78 22.9* 0.49   0.07 48.4** 3.90   0.29 47.8*
C2 1.12   0.09 29.60   1.92 0.95   0.10 7.48   1.04
48 T2 1.36   0.16 0.76** 18.00   0.98 52.8*** 0.43   0.05 5.7 3.28   0.30 39.4**
C2 0.60   0.07 38.20   2.88 1.00   0.05 5.42   0.48
72 T2 1.94   0.29 0.94* 19.00   2.29 35.8*** 0.49   0.06 57.01*** 1.92   0.15 34.6*
C2 1.00   0.13 29.60   1.78 1.14   0.11 2.94   0.32
96 T2 2.48   0.21 1.20** 13.80   1.29 43.9*** 0.43   0.05 63.5*** 0.16   1.18 94.7***
C2 1.28   0.20 24.60   1.52 1.18   0.07 3.02   0.22
N 1.40   0.06 1.47   0.23 0.14   0.05 0.69   0.11
Suppr, Suppression; N, normal control.
*P   0.05; **P   0.01; ***P   0.001.As compared to the total frequencies of chromosome abera-
tions (1.47%) in the normal healthy control there was a
considerable increase in the frequencies of chromosome aber-
ations in the mercuric chloride-treated series at all intervals of
fixation. However, a critical analysis of the data revealed that
pre-feeding of the drug helped suppression of aberrations to
a varying degree at all fixation intervals, except at 12 h in
the Merc Sol-30-fed series (Table 1). However, again the Merc
Sol-200 showed a marginally better efficacy vis-à-vis
Merc Sol-30 (Figs 2 and 3). As compared to untreated normal
healthy mice showing 0.14% micronuclei, the frequencies of
micronuclei in the mercuric chloride-treated mice were invari-
ably enhanced at all intervals of fixation. On the other hand, in
the drug-fed series there were suppressions of micronuclei at
various fixation intervals, most of which were statistically sig-
nificant (between P   0.01 and P   0.001, Table 1). In case of
micronuclei (which are generally expected to manifest more
after 30 h, i.e. after the completion of first cell cycle) the Merc
Sol-30 apparently had a marginally better efficacy.
As compared to 0.69% sperm showing abnormal head
morphology in normal healthy control mice, there was gener-
ally an increase in their total frequencies at all intervals of
fixation in the mercuric chloride-treated mice. However, the
percentages of suppression in the frequencies of abnormal
sperm in the drug-fed series was not so pronounced at some
fixation intervals, particularly in the Merc Sol-30-fed series
(see Table 1), though there was a marginally better efficacy
shown by Merc Sol-200.
Post-feeding
The same trend of a generally lower mitotic index shown in
mercuric chloride-treated mice as compared to untreated normal
ones and increase in the drug-fed series was also noticed in the
post-fed mice (Table 2, Figs 4 and 5). A critical analysis of the
data revealed that in the post-fed series the degree of
suppression was visibly greater than in the pre-fed series
in most of the parameters studied. Further, the degree of
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Table 3. Frequency distribution of mitotic index, chromosome aberations, micronuclei, and sperm head anomaly in mice at different fixation intervals in 
pre- and post-fed mercuric chloride-treated mice
Fixation interval Series Mitotic index Chromosome aberations Micronucleated erythrocytes Sperm head anomaly
(h) % (%   SE) % increase Total (%   SE) % Suppr Total (%   SE) % Suppr Total (%   SE) % Suppr
Pre and post-fed with Merc Sol-30 (T3) and Alc-30 (C3)
6T 3 1.40   0.15 0.00 9.20   1.14 19.3 1.06   0.24 (–)
C3 1.40   0.12 11.40   1.44 0.52   0.09
12 T3 1.90   0.13 1.11*** 8.40   1.03 41.7 0.33   0.02 45.9** 1.44   0.35 17.2
C3 0.88   0.08 14.40   2.56 0.61   0.06 1.74   0.30
24 T3 2.06   0.19 0.92** 20.60   2.16 23.7* 0.49   0.03 32.8 3.70   0.23 52.1***
C3 1.14   0.08 27.00   1.83 0.73   0.19 7.72   0.39
48 T3 1.84   0.19 1.06*** 16.20   1.47 55.0*** 0.43   0.02 62.9*** 3.12   0.27 43.8**
C3 0.78   0.07 36.00   3.18 1.16   0.09 5.56   0.46
72 T3 2.08   0.23 1.10*** 19.20   2.38 31.4* 0.61   0.04 51.5*** 1.78   0.07 38.2*
C3 0.98   0.15 28.00   2.09 1.26   0.10 2.88   0.34
96 T3 2.46   0.21 1.10*** 13.00   1.11 42.9*** 0.45   0.05 61.8*** 1.26   0.19 55.9***
C3 1.36   0.17 22.80   1.55 1.18   0.07 2.86   0.23
Pre and post-fed with Merc Sol-200 (T3) and Alc-200 (C3)
6T 3 1.52   0.10 0.20 7.60   0.83 36.7* 0.40   0.11 60.8
C3 1.34   0.13 12.20   1.29 1.02   0.28
12 T3 2.14   0.13 1.42*** 6.40   1.03 56.7** 0.23   0.02 62.3** 1.34   0.35 27.0
C3 0.72   0.17 14.80   2.07 0.61   0.08 1.84   0.25
24 T3 2.22   0.42 1.18* 18.60   1.92 35.5** 0.33   0.05 66.7*** 3.32   0.20 54.2***
C3 1.04   0.10 28.80   1.85 0.99   0.10 7.24   0.50
48 T3 2.10   0.22 1.38*** 13.80   1.71 63.2*** 0.27   0.02 74.2*** 2.80   0.24 49.3***
C3 0.72   0.06 37.40   2.86 1.08   0.06 5.52   0.47
72 T3 2.42   0.28 1.48** 16.80   2.16 40.8** 0.31   0.05 73.7*** 1.62   0.13 43.3**
C3 0.94   0.12 28.40   1.75 1.18   0.12 2.86   0.30
96 T3 2.80   0.29 1.46** 11.20   1.29 52.6*** 0.23   0.04 79.2*** 0.98   0.12 66.7***
C3 1.34   0.19 23.60   1.35 1.11   0.07 2.94   0.21
N 1.40   0.06 1.47   0.23 0.14   0.05 0.69   0.11
Suppr, Suppression; N, normal control.
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(a) (b)
(c) (d)
(e) (f)
(g) (h) (i) (j)
(k) (l) (m) (o) (n)
Figure 1. (A–F) Photomicrographs of metaphase complements showing: (A)
break (BS); (B) terminal association (TA) and precocious centromeric separa-
tion (PCS); (C) ring (RS) and gap (GS); (D) fragment (F); (E) polyploidy; and
(F) pulverisation. (G–J) Bone marrow smears showing micronucleated erythro-
cytes: (G and H) polychromatic and (I and J) normochromatic erythrocytes.
(K–O) Photomicrographs of sperm showing various abnormal head shapes.
amelioration was also marginally better in the Merc 
Sol-200-fed series as compared to that of the Merc Sol-30-fed
series.
Combined Pre- and Post-feeding
The same trend of a generally lower mitotic index shown
in mercuric chloride-treated mice as compared to untreated
normal ones and increase in the drug-fed series was also
noticed in the combined pre- and post-fed mice. However,
on a comparative basis the combined pre- and post-feeding
brought forth much more amelioration in terms of the genotoxic
parameters studied. Similarly, Merc Sol-200 showed a slightly
more pronounced effect, particularly at 96 h, than that of the
Merc Sol-30-fed series (Table 3, Figs 6 and 7). On the whole
the degree of amelioration provided by pre- and post-feeding
of the drug was more pronounced than that of either pre- or
post-feeding alone, and the post-feeding mode showed better
ameliorative potential than that of pre-feeding alone.
Discussion
Mercuric chloride is an extremely toxic salt. In the present
study, even a single injection at a sub-lethal dose produced
genotoxic effects in mice as revealed from the enhanced
frequencies of chromosome aberrations, micronuclei in the
bone marrow cells and increased frequencies of sperm head
abnormality. While the chromosome aberations would provide
evidence of damaging effects of mercuric chloride on the
genome (hereditary vehicles) of mice, the occurrence
of micronuclei also provides an indirect measurement of the
induction of structural chromosome aberations. Micronuclei
are small chromatin-containing bodies arising from the chro-
mosomes that failed to incorporate into daughter nuclei
following mitosis. The genotoxic effects appeared to increase
gradually up to 72 h, after which they showed signs of a
decline. In keeping with our findings, Kato (16) reported
chromosome breakage associated with treatment of organic
mercury in Chinese hamster cells in vitro. In earlier studies,
mercury and other derivatives of mercury such as phenyl and
methyl mercury have also been reported to produce chromosome
abnormalities, induce genetic and teratogenic effects and
to inhibit spindle formation during mitosis in rats (see 10 for
review). Further, Das et al. (17) also demonstrated that
mercuric chloride altered DNA and RNA synthesis. Some
macro molecular agents such as thiol compounds, selenium,
some vitamins, e.g. D and E, and some antioxidants had earlier
been reported to have important antagonistic effects to mercury
poisoning (10). But this seems to be the first report on the abil-
ity of a homeopathic drug to act as an effective antagonist of
mercury poisoning. Interestingly, in the present study both the
30th and 200th potencies of Merc Sol, which contained hardly
a single original molecule of the drug ingredient (theoretically
speaking), appeared to effectively ameliorate the genotoxic
effects produced by mercuric chloride. Incidentally, chromo-
somes are made up mainly of DNA and protein. There is an
intrinsic mechanism of repair and retrieval of DNA, under
strict genetic control in most organisms, including mice. In
mice, specific genes are activated when there is any breakage
or insult to DNA by any clastogenic/mutagenic agent (e.g.
XPA gene for damage recognition, XPB and XPD for helicase
activity, XPC for DNA binding etc.) and a lot of gene activity
has been documented (e.g. genes rec A, lex A, uvr A, uvr B,
umu C, him A etc.) for taking corrective measures to repair the
damage (18,19). In the present study, repair of chromosome
damage has been noted in a steadily enhanced rate in the
homeopathic drug-fed mice as compared to that in the mercuric
chloride-treated but drug-unfed mice. Therefore, one hypothesis
to explain the ability of the potentized homeopathic drugeCAM 2004;1(3) 297
Figure 2. Frequency distribution of MI, CA, MN and SHA in mice at different fixation intervals in mercuric chloride treated mice pre-fed with Merc Sol-30 (T1),
alcohol-30 (C1) and normal controls (N).
Figure 3. Frequency distribution of MI, CA, MN and SHA in mice at different fixation intervals in mercuric chloride treated mice pre-fed with Merc Sol-200
(T1), alcohol-200 (C1) and normal controls (N).298 Homeopathy for mercury-induced genotoxicity
Figure 5. Frequency distribution of MI, CA, MN and SHA in mice at different fixation intervals in mercuric chloride treated mice post-fed with Merc Sol-200
(T2), alcohol-200 (C2) and normal controls (N).
Figure 4. Frequency distribution of MI, CA, MN and SHA in mice at different fixation intervals in mercuric chloride treated mice post-fed with Merc Sol-30
(T2), alcohol-30 (C2) and normal controls (N).eCAM 2004;1(3) 299
Figure 6. Frequency distribution of MI, CA, MN and SHA in mice at different fixation intervals in mercuric chloride treated mice pre- and post-fed with Merc
Sol-30 (T3), alcohol-30 (C3) and normal controls (N).
Figure 7. Frequency distribution of MI, CA, MN and SHA in mice at different fixation intervals in mercuric chloride treated mice pre- and post-fed with Merc
Sol-200 (T3), alcohol-200 (C3) and normal controls (N).(without any materialistic drug ingredient) to enhance the
repair process, could possibly be by way of sending/carrying
positive signals for faster and effective repair through inducing
the right genes or inhibiting others involved in the process of
chromosome repair. Incidentally, the repair of protein (includ-
ing that in sperm head) would also need the corrective action
taken by certain genes controlling transcription/translation
responsible for maintaining structural integrity of the particu-
lar type of protein (in chromosomes or sperm).
Another feature worth noting was that both potencies of
Merc Sol appeared to considerably increase the mitotic index
of cells, showing direct antagonism (regulatory action) to the
mitotic inhibitory effect of mercuric chloride. A similar mitotic
enhancement had also been noted in the repair of X-ray-
induced chromosome damage by potentized homeopathic
drugs (20,21). On the other hand, during artificial induction of
hepatocarcinoma in mice by p-DAB, when the mitotic index
was becoming increasingly enhanced (prior to tumor formation),
a homeopathic drug, Chelidonium, combated it by effectively
reducing the divisional activity of hepatocytes (22). Thus, one
of the pathways through which the drugs appeared to work
was apparently by inducing or inhibiting (i.e. natural regula-
tion) divisional activities of the cells involved. In the present
study, more divisional activity was necessary to replenish the
cells that might have been lost owing to the clastogenic and
mitotoxic effects of mercuric chloride. Incidentally, the cell
cycle progression in all living organisms is strictly under
genetic control. For a cell to progress through a cell cycle,
phosphorylation (by several kinases, mainly products of cdc-2
genes) and dephosphorylation (by phosphatases, mainly prod-
ucts of cdc-25 genes) of substrates are the basic requirements
(18,19) with the active involvement of several other genes like
p-34, p-53, p-21 and some proto-oncogenes (e.g. c-mos) in the
process. Thus, the ability of the potentized homeopathic drug
to modulate cell cycles could be explained by assuming that
the homeopathic drug actually had a regulatory role on the
expression of some relevant genes, possibly through a signal
transduction mechanism in a bid to step up the recovery
process. Thus, the administration of the ultra-diluted homeo-
pathic drug was found not only to reduce the mercuric
chloride-induced genotoxicity (Merc Sol-200 showing slightly
more pronounced effects), but the results of the present study
would also lend support to the contention that one way through
which the potentized homeopathic drugs act could indeed be
by way of regulating expression of certain genes (8,23,24) and
that the principle of ‘like cures like’also holds true in the pres-
ent case, as shown convincingly in the case of Arsenicum
album against arsenic intoxication (8).
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